Charles River Laboratories (CRL) Tops Q1 EPS by 5c
Tweet Send to a FriendGet Alerts CRL Hot Sheet
Price: $42.56 --0%
EPS Growth %: -1.4%
Financial Fact:
Provision (benefit) for income taxes: 9.72M
Today's EPS Names:
CLC, FNSR, MU, More
EPS Growth %: -1.4%
Financial Fact:
Provision (benefit) for income taxes: 9.72M
Today's EPS Names:
CLC, FNSR, MU, More
Trade CRL Now!
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $286 million versus the consensus estimate of $286.21 million.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Downgrades Charles River Labs (CRL) to Sell; Sees 12% Downside
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
